ISG15 and hepatocellular carcinoma: Spleen-targeted neoantigen mRNA vaccine induces ISG15&lt;sup&gt;+&lt;/sup&gt; CD8&lt;sup&gt;+&lt;/sup&gt; T cell-mediated tertiary lymphoid structure formation in hepatocellular carcinoma.